Bon Natural Life Ltd (BON)

$1.67

-0.06

(-3.46%)

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $1.65
    $1.73
    $1.67
    downward going graph

    1.2%

    Downside

    Day's Volatility :4.62%

    Upside

    3.47%

    downward going graph
  • $1.58
    $6.99
    $1.67
    downward going graph

    5.39%

    Downside

    52 Weeks Volatility :77.39%

    Upside

    76.11%

    downward going graph

Returns

PeriodBon Natural Life LtdIndex (Russel 2000)
3 Months
-13.92%
0.0%
6 Months
-62.83%
0.0%
1 Year
-72.4%
0.0%
3 Years
-98.43%
-22.3%

Highlights

Market Capitalization
6.6M
Book Value
$30.23
Earnings Per Share (EPS)
5.0
PE Ratio
0.33
Wall Street Target Price
77.5
Profit Margin
15.57%
Operating Margin TTM
19.08%
Return On Assets TTM
8.83%
Return On Equity TTM
13.78%
Revenue TTM
29.5M
Revenue Per Share TTM
32.3
Quarterly Revenue Growth YOY
-5.2%
Gross Profit TTM
9.4M
EBITDA
6.9M
Diluted Eps TTM
5.0
Quarterly Earnings Growth YOY
-0.41
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 4540.72%

Current $1.67
Target $77.50

Company Financials

FY18Y/Y Change
Revenue
10.8M
-
Net Income
223.4K
-
Net Profit Margin
2.07%
-
FY19Y/Y Change
Revenue
16.4M
↑ 52.07%
Net Income
2.6M
↑ 1052.23%
Net Profit Margin
15.7%
↑ 13.63%
FY20Y/Y Change
Revenue
18.2M
↑ 11.12%
Net Income
3.0M
↑ 17.6%
Net Profit Margin
16.61%
↑ 0.91%
FY21Y/Y Change
Revenue
25.5M
↑ 39.93%
Net Income
4.6M
↑ 51.68%
Net Profit Margin
18.01%
↑ 1.4%
FY22Y/Y Change
Revenue
29.9M
↑ 17.31%
Net Income
6.2M
↑ 35.87%
Net Profit Margin
20.86%
↑ 2.85%
FY23Y/Y Change
Revenue
29.5M
↓ 1.29%
Net Income
4.6M
↓ 26.32%
Net Profit Margin
15.57%
↓ 5.29%
Q2 FY22Q/Q Change
Revenue
8.1M
-
Net Income
1.8M
-
Net Profit Margin
22.74%
-
Q4 FY22Q/Q Change
Revenue
7.1M
-
Net Income
1.1M
-
Net Profit Margin
14.98%
-
Q1 FY23Q/Q Change
Revenue
14.1M
↑ 100.0%
Net Income
2.1M
↑ 100.0%
Net Profit Margin
14.98%
↑ 0.0%
Q2 FY23Q/Q Change
Revenue
15.4M
↑ 8.64%
Net Income
2.5M
↑ 16.82%
Net Profit Margin
16.11%
↑ 1.13%
FY18Y/Y Change
Total Assets
16.6M
-
Total Liabilities
12.1M
-
FY19Y/Y Change
Total Assets
19.6M
↑ 17.52%
Total Liabilities
12.3M
↑ 1.64%
FY20Y/Y Change
Total Assets
25.2M
↑ 28.84%
Total Liabilities
14.2M
↑ 15.31%
FY21Y/Y Change
Total Assets
36.4M
↑ 44.48%
Total Liabilities
9.9M
↓ 30.33%
FY22Y/Y Change
Total Assets
37.3M
↑ 2.32%
Total Liabilities
7.2M
↓ 27.47%
FY23Y/Y Change
Total Assets
46.6M
↑ 24.96%
Total Liabilities
10.6M
↑ 47.6%
Q2 FY22Q/Q Change
Total Assets
37.3M
↓ 5.39%
Total Liabilities
7.2M
↓ 26.45%
Q3 FY22Q/Q Change
Total Assets
37.3M
↑ 0.0%
Total Liabilities
7.2M
↑ 0.0%
Q4 FY22Q/Q Change
Total Assets
47.2M
↑ 26.71%
Total Liabilities
11.7M
↑ 63.38%
Q1 FY23Q/Q Change
Total Assets
47.2M
↑ 0.0%
Total Liabilities
11.7M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
46.6M
↓ 1.38%
Total Liabilities
10.6M
↓ 9.66%
Q3 FY23Q/Q Change
Total Assets
46.6M
↑ 0.0%
Total Liabilities
10.6M
↑ 0.0%
FY18Y/Y Change
Operating Cash Flow
273.9K
-
Investing Cash Flow
-1.7M
-
Financing Cash Flow
2.0M
-
FY19Y/Y Change
Operating Cash Flow
7.1M
↑ 2493.98%
Investing Cash Flow
-8.4M
↑ 400.41%
Financing Cash Flow
804.7K
↓ 60.12%
FY20Y/Y Change
Operating Cash Flow
2.6M
↓ 62.8%
Investing Cash Flow
-3.0M
↓ 64.38%
Financing Cash Flow
112.5K
↓ 86.02%
FY21Y/Y Change
Operating Cash Flow
4.1M
↑ 53.35%
Investing Cash Flow
-7.4M
↑ 147.87%
Financing Cash Flow
5.4M
↑ 4658.28%
FY22Y/Y Change
Operating Cash Flow
-187.1K
↓ 104.62%
Investing Cash Flow
-3.1M
↓ 58.95%
Financing Cash Flow
2.3M
↓ 57.75%
Q1 FY22Q/Q Change
Operating Cash Flow
-65.3K
↑ 0.0%
Investing Cash Flow
-995.8K
↑ 0.0%
Financing Cash Flow
912.2K
↑ 0.0%
Q2 FY22Q/Q Change
Operating Cash Flow
-28.3K
↓ 56.7%
Investing Cash Flow
-532.0K
↓ 46.57%
Financing Cash Flow
218.5K
↓ 76.04%
Q3 FY22Q/Q Change
Operating Cash Flow
-28.3K
↑ 0.0%
Investing Cash Flow
-532.0K
↑ 0.0%
Financing Cash Flow
218.5K
↑ 0.0%
Q4 FY22Q/Q Change
Operating Cash Flow
-1.1M
↑ 3751.85%
Investing Cash Flow
-9.1K
↓ 98.3%
Financing Cash Flow
957.5K
↑ 338.13%
Q1 FY23Q/Q Change
Operating Cash Flow
-2.2M
↑ 100.0%
Investing Cash Flow
-9.1K
↑ 0.0%
Financing Cash Flow
1.9M
↑ 100.0%

Technicals Summary

Sell

Neutral

Buy

Bon Natural Life Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bon Natural Life Ltd
Bon Natural Life Ltd
-14.88%
-62.83%
-72.4%
-98.43%
-97.68%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
-3.15%
9.6%
-8.01%
0.6%
24.2%
Linde Plc
Linde Plc
3.39%
-1.81%
18.17%
44.74%
146.67%
Dupont De Nemours Inc
Dupont De Nemours Inc
2.49%
11.17%
4.74%
10.81%
12.24%
Sherwin-williams Company, The
Sherwin-williams Company, The
6.22%
4.69%
33.07%
19.15%
106.97%
Ecolab Inc.
Ecolab Inc.
5.83%
9.12%
34.88%
7.89%
22.05%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bon Natural Life Ltd
Bon Natural Life Ltd
0.33
0.33
NA
0.0
0.14
0.09
NA
30.23
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
23.76
23.76
1.46
12.34
0.16
0.05
0.03
67.93
Linde Plc
Linde Plc
34.85
34.85
2.57
15.53
0.16
0.07
0.01
79.96
Dupont De Nemours Inc
Dupont De Nemours Inc
104.13
104.13
0.45
3.77
0.01
0.03
0.02
55.9
Sherwin-williams Company, The
Sherwin-williams Company, The
36.63
36.63
3.99
11.49
0.68
0.1
0.01
14.95
Ecolab Inc.
Ecolab Inc.
41.32
41.32
2.38
6.62
0.22
0.07
0.01
23.46
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bon Natural Life Ltd
Bon Natural Life Ltd
NA
$6.6M
-97.68%
0.33
15.57%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
Buy
$60.8B
24.2%
23.76
21.24%
Linde Plc
Linde Plc
Buy
$222.3B
146.67%
34.85
19.49%
Dupont De Nemours Inc
Dupont De Nemours Inc
Buy
$34.0B
12.24%
104.13
5.51%
Sherwin-williams Company, The
Sherwin-williams Company, The
Buy
$91.0B
106.97%
36.63
10.92%
Ecolab Inc.
Ecolab Inc.
Hold
$70.2B
22.05%
41.32
10.95%

Insights on Bon Natural Life Ltd

  • Vs ECL

    In the last 1 year, Ecolab Inc. has given 34.9% return, outperforming this stock by 107.3%

  • Vs LIN

    In the last 3 years, Linde Plc has given 7.9% return, outperforming this stock by 106.3%

Institutional Holdings

    Company Information

    bon natural life was founded in 2006, is engaged in the research and development, production, and sales of plant extracts in china. dedicated to functional food, personal care and other fields to provide plant active ingredients and compound product solutions.<br> the company is headquartered in xi'an high-tech zone, shaanxi province, china with independent research and development center and testing laboratory, with two production bases in weinan and tongchuan, a new production base in yumen, gansu province under construction, marketing network coverage at home and abroad.bon has obtained production and operation license, iso9001 quality management system certification, iso22000 food safety management system certification, fda inspection certification, kosher, halal and other certifications. in the field of plant extracts, the production and sales of bon meet the relevant national standards and requirements.<br> as a high-tech enterprise driven by technology, bon has applied for

    Organization
    Bon Natural Life Ltd
    Employees
    96
    CEO
    Mr. Yongwei Hu
    Industry
    Miscellaneous

    FAQs